Evidence map›Paper›PMID 42260177›Full record

ArticleEMBO reports2026

Caspase-8 silences cell death-independent constitutive immune activation driven by tonic TNF-α.

Germana Lentini, Francesco Coppolino, Agata Famà, Giuseppe Valerio De Gaetano, Federica Grasso, Luigi Fiore, Alessia Berbiglia, Silvia Carnevale, Isabella Venza, Egil Lien and 4 more

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Germana LentiniDepartment of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy.ORCID 0000-0002-0572-4476
Francesco CoppolinoDepartment of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy.ORCID 0000-0002-9672-0824
Agata FamàDepartment of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy.
Giuseppe Valerio De GaetanoDepartment of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy.
Federica GrassoDepartment of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy.
Luigi FioreDepartment of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy.
Alessia BerbigliaDepartment of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy.
Silvia CarnevaleHumanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy.ORCID 0000-0002-9176-5636
Isabella VenzaDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Egil LienDivision of Infectious Diseases and Immunology, Program in Innate Immunity, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.ORCID 0000-0002-8536-2419
Mario VenzaDepartment of Biomedical and Dental Sciences and Morphological and Functional Images, University of Messina, Messina, Italy.
Sebastien JaillonHumanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy.
Giuseppe TetiScylla Biotech Srl, Messina, Italy. gioteti@mac.com.ORCID 0000-0002-6315-8644
Concetta BeninatiDepartment of Human Pathology "Gaetano Barresi", University of Messina, Messina, Italy.ORCID 0000-0001-8305-1337

Funding

Caspase-8 as a focal hub in effector-triggered immunityR01AI146855 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIEN, EGIL · 2019 to 2023
$2.9M
Fondazione AIRC per la ricerca sul cancro ETS (AIRC) Fellowship recipientFondazione AIRC per la ricerca sul cancro ETS (AIRC) IG 30335HHS | National Institutes of Health (NIH) R01AI146855Ministero dell'Università e della Ricerca (MUR) CUP B83C22002860006Ministero dell'Università e della Ricerca (MUR) CUP J53D23014110001Ministero dell'Università e della Ricerca (MUR) S1.P0002NIAID NIH HHS R01 AI146855Università degli Studi di Messina (UNIME) APC initiative publication expenses
6 · The paper itself

Abstract

Caspase-8 is essential for maintaining organismal integrity by preventing cell death and subsequent inflammation in specific epithelial and endothelial tissues. Here, we show that caspase-8 also controls a systemic, cell death-independent inflammatory pathway that is constitutively active during homeostasis. In vivo, selective caspase-8 inhibition produces, in the absence of other stimuli, marked neutrophilia driven by circulating proinflammatory and chemotactic cytokines and promotes bacterial clearance during infection. In vitro, caspase-8 inhibition triggers in neutrophils, but not in macrophages, a profound transcriptional response associated with the release of IL-1β and other cytokines. This process requires tonic TNF-α production by neutrophils, which acts autocrinally to sequentially activate RIPK1, RIPK3, MAPKs, and NF-κB. The IL-1β release induced by caspase-8 inhibition requires gasdermin D and neutrophil serine proteases, but not canonical inflammasome components. Our data uncover the mechanistic features of a neutrophil-centric, proinflammatory pathway that can be therapeutically targeted to augment host defenses against pathogens.

Indexed as

Caspase 8Tumor Necrosis Factor-alphaAnimalsCell DeathInflammationInterleukin-1betaMacrophagesMiceNeutrophilsNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesSignal TransductionCaspase 8Interleukin-1betaNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesRipk3 protein, mouseTumor Necrosis Factor-alpha

Identifiers

PMID42260177
PMCPMC13400634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.